By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Accelrys announced today the completion of its merger with Symyx, following approval by both companies' shareholders.

The completion of the merger follows the satisfaction of certain conditions and shareholder meetings held on Wednesday by Accelrys and Symyx to vote on the merger, under which terms Symyx shareholders will receive 0.7802 shares of Accelrys stock for each share of Symyx they own.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: gene linked to expansion of the human neocortex, and more.

The National Institute of General Medical Sciences director says changes the agency made have allow it to boost success rates.

Ancient DNA indicates Stone Age, hunter-gather inhabitants of Britain imported wheat.

Joel Achenbach explores at National Geographic why people find science difficult to believe.